Klotho Neurosciences, Inc.

NasdaqGM:KLTO Stock Report

Market Cap: US$10.0m

Klotho Neurosciences Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of KLTO?
Owner TypeNumber of SharesOwnership Percentage
Institutions2,452,75311.5%
Private Companies4,383,92520.6%
General Public6,808,23832%
Individual Insiders7,618,59935.8%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 141.6%.

Top Shareholders

Top 19 shareholders own 67.98% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
16.5%
Joseph Sinkule
3,514,932US$1.7m39.8%no data
14.4%
Gan Min
3,063,667US$1.4m-1.65%no data
13.1%
Upper Clapton, LLC
2,773,925US$1.3m0%no data
7.64%
Chardan Capital Markets, LLC., Asset Management Arm
1,625,000US$763.8k8.33%44.06%
7.57%
Geneva Holdings Company (GHC) SA
1,610,000US$756.7k0%no data
2.51%
Meteora Capital, LLC
533,951US$251.0k36.3%0.07%
1.88%
Shalom Hirschman
400,000US$188.0k0%no data
1.76%
Samuel Zentman
375,000US$176.2k-3.85%no data
0.94%
Peter Moriarty
200,000US$94.0k0%no data
0.47%
Morgan Stanley, Investment Banking and Brokerage Investments
100,000US$47.0k0%no data
0.38%
MM Asset Management Inc
80,000US$37.6k0%no data
0.3%
Geode Capital Management, LLC
63,234US$29.7k1,980%no data
0.16%
Cong Wang
35,000US$16.4k0%no data
0.14%
Jon McGarity
30,000US$14.1k0%no data
0.12%
GAMCO Investors, Inc.
25,000US$11.7k0%no data
0.072%
UBS Asset Management AG
15,306US$7.2k59.5%no data
0.047%
Gabelli & Company Investment Advisers, Inc.
10,000US$4.7k0%no data
0.0012%
Bank of America Corporation, Asset Management Arm
261US$122.938.1%no data
0%
Palmer Square Capital Management LLC
1US$00%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 09:13
End of Day Share Price 2024/12/26 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Klotho Neurosciences, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution